Infectious Diseases in Ob-Gyn
Paul R. Summers, M.D.
Associate Professor
Department of Obstetrics and Gynecology
Objectives
Definitions
Outline
Take Home Points
Objectives
At the end of this lecture you should be able to:
- Recognize clinical signs and symptoms of common types of vaginitis
- Recognize clinical signs and symptoms of common sexually transmitted diseases
- Understand basic vaginitis and sexually transmitted disease therapy
- Understand the basic issues of HIV in women

Definitions
Strawberry Cervix: diffusely visible punctate cervical erythema
Cobblestone Vagina: Thickening of the natural vaginal folds due to chronic vaginitis
Mucopurulent Endocervicitis: yellow or brown pus in the endocervical canal
Dysplasia: pre-cancerous change in the cervical epithelium

Outline
- Lower Tract Infections
- Upper Tract Infections
- Sexually Transmitted Diseases
- HIV in Women

Outline
- Lower Tract Infection
- Candida
- typically Candida albicans but non-albicans rising prevalence
- sexual transmission not clinically significant
- epithelial microtrauma probably allows infection to develop
- immunocompromise must be considered in recurrent cases
- AIDS
- endocrinopathies
- autoimmune diseases (Lupus, RA, temporal arteritis)
- leukemia, lymphoma, etc
- patients on chemotherapy
- responds well to topical antifungal agents
- 150 mg fluconazole now approved as single oral dose therapy
- Trichomonas
- strawberry cervix, cobblestone vagina
- sexually transmitted
- responds well to metronidazole
- Bacterial Vaginosis
- related to loss of hydrogen peroxide-producing lactobacilli
- associated with Gardnerella and Mobiluncus species
- pathogen that inhibits lactobacilli has not been identified
- sexually transmitted in most cases
- but treatment of male not usually necessary
- instigating microbe autoeliminates after a few days?
- responds well to metronidazole or cleocin (oral or topical)
- similar to an abscess in types and numbers of organisms
- Upper Tract Infection
Salpingitis
- initially due to gonococcus
- quickly becomes polymicrobial (aerobic/anaerobic)
- actinomyces can cause unilateral salpingitis (oophoritis)
- role for chlamydia postulated but not proven
- broad spectrum antibiotic therapy is necessary
- Sexually Transmitted Diseases
- Human Papillomavirus Infection
- strains 6,11--low malignant potential
- strains 16, 18--potential for malignant transformation
- virus persist for many years in the genital epithelium
- high prevalence (30% of college students PCR positive)
- therapeutic goal is generally cosmetic
- high recurrence (persistence) rate with standard therapies cryotherapy, podophyllin, bichloroacetic acid, laser
- add local interferon injections for recurrent cases
- Chlamydia
- significant pathogen for men (urethral strictures, Reiter's)
- significant pathogen for infants (conjunctivitis, pneumonia)
- potential pathogen for women (immune salpingitis?)
- produces mucopurulent endocervicitis in some cases
- responds well to tetracycline, erythromycin
- single dose therapy with 1 gm azithromycin
- Gonorrhea
- 50% of patients will also have chlamydia
- less than 3% of strains produce penicillinase
- produces mucopurulent endocervicitis in some cases
- significant risk for salpingitis
- responds well to ceftriaxone, quinolone antibiotics
- Herpes simplex
- clinical virulence may be declining?
- high risk of spread to other sites (eyes) and to others
- responds well to acyclovir
- Syphilis
- rising prevalence
- a rash in an adult is syphilis until proven otherwise
- benzathine penicillin is standard therapy
- we need new therapies
- AIDS patients progress in spite of penicillin
- penicillin-allergic patients present a problem
- Chancroid
- epidemic in coastal cities
- incidence in men 10 times females
- results in painful lymphadenopathy
- responds well to ceftriaxone, erythromycin
- H. ducreyi produces penicillinase
- Hepatitis B
- infection is generally asymptomatic
- 50% of carriers do not show hepatitis risk factors
- up to 30% risk of perinatal spread from maternal carrier
- infectious risk is greatest if mother surface and E antigen +
- all infants should be vaccinated for hepatitis
- HIV in Women
- 11% of U.S. HIV cases are female
- 6th leading cause of death in young women in 1989
- 6000 HIV infected deliveries in the U.S. per year
- In Africa, 5-10% of infants HIV positive, 40% of 30-34 year olds positive
- risk of perinatal transmission is 10-50% (average around 25%)
- maternal factors increase the risk of transmission:
- preterm labor before 34 weeks
- severity of mother's illness
- prior delivery of an infected infant
- immunocompromise
- prolonged labor
- C-section may lower the rate of HIV transmission in asymptomatic cases
- pregnancy probably does not alter course of maternal HIV
- ziduvidine is offered during pregnancy
- if CD4 count is low
- as prophylaxis to lower perinatal transmission rate to 8%
- Female to male heterosexual transmission rate is lower than Male to Female
- Virus is in semen, cervical secretions, blood
- CD4 receptor sites are not prevalent in the vagina
- inflammation causes CD4 lymphocytes, macrophages, Langerhans cells to appear in the vagina
- rapid progression of dysplasia to invasive cervical cancer in AIDS

Take Home Points
- The pathophysiology of vulvovaginal candidiasis is not well understood.
- Vulvovaginal candidiasis should respond well to any oral or topical antifungal
agent.
- It is not generally necessary to treat the male for Bacterial Vaginosis.
- Limited-spectrum therapy that only covers the gonococcus is only appropriate for asymptomatic gonorrhea carriers.
- Broad-spectrum therapy that also covers gram positive bacteria and anaerobic bacteria is necessary for all cases of symptomatic salpingitis.
- The main goal of genital Human Papillomavirus infection is cosmetic, and may not influence transmission rate.
- Endocervical chlamydia and gonococcal infection is often totally asymptomatic.
- A rash in an adult is syphilis (or early HIV infection) until proven otherwise.
- The risk of transmission of HIV to the newborn of an HIV-infected mother can be decreased by 2/3 if prenatal, intrapartum, and postpartum ziduvidine is administered.
